EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PO057 | IS PLATELET FUNCTION TESTING CLINICALLY USEFUL IN PATIENTS WITH CHRONIC SUBDURAL HEMATOMA UNDERGOING NEUROSURGERY WHILE ON ANTIPLATELET THERAPY?

Giulia Ciarrocca Taranta

Bleeding, Thrombosis and Vascular Biology · 26.10.2026 · 5 (s3)

DOI: 10.4081/btvb.2026.873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bleeding, Thrombosis and Vascular Biology, online erschienen am 26.10.2026. Verfasst von Giulia Ciarrocca Taranta. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims. Patients undergoing neurosurgery are increasingly treated with antiplatelet therapy, which increases bleeding risk and complicates the management of chronic subdural hematoma (CSDH), a condition for which clear guidelines are lacking. Platelet function testing may help optimize the timing of neurosurgical intervention by balancing hemorrhagic and thrombotic risks, given the variability in individual responses to antiplatelet drugs. This study aims to evaluate the safety and clinical utility of platelet reactivity testing in patients undergoing neurosurgical evacuation of CSDH.Methods. We conducted a case–control study including patients undergoing surgical evacuation of CSDH between 2022 and 2025. Cases were patients on antiplatelet therapy with an urgent surgical indication who showed early normalization of platelet function on reactivity testing (i.e., normalization before the recommended drug withdrawal period). Controls were patients not receiving antiplatelet therapy. Outcomes included early complications (

Zitieren

APA

Taranta, G. C. (2026). PO057 | IS PLATELET FUNCTION TESTING CLINICALLY USEFUL IN PATIENTS WITH CHRONIC SUBDURAL HEMATOMA UNDERGOING NEUROSURGERY WHILE ON ANTIPLATELET THERAPY?. Bleeding, Thrombosis and Vascular Biology, 5(s3). https://doi.org/10.4081/btvb.2026.873

Vancouver

Taranta GC. PO057 | IS PLATELET FUNCTION TESTING CLINICALLY USEFUL IN PATIENTS WITH CHRONIC SUBDURAL HEMATOMA UNDERGOING NEUROSURGERY WHILE ON ANTIPLATELET THERAPY?. Bleeding, Thrombosis and Vascular Biology. 2026;5(s3). doi:10.4081/btvb.2026.873

BibTeX
@article{Taranta2026,
  author = {Taranta, Giulia Ciarrocca},
  title = {PO057 | IS PLATELET FUNCTION TESTING CLINICALLY USEFUL IN PATIENTS WITH CHRONIC SUBDURAL HEMATOMA UNDERGOING NEUROSURGERY WHILE ON ANTIPLATELET THERAPY?},
  journal = {Bleeding, Thrombosis and Vascular Biology},
  year = {2026},
  volume = {5},
  number = {s3},
  doi = {10.4081/btvb.2026.873}
}
Kostenlos starten →